| Year |
Citation |
Score |
| 2013 |
Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC, Durr E, Espeseth AS, Casimiro DR, Zhang N, Shiver JW, Wang D, et al. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proceedings of the National Academy of Sciences of the United States of America. 110: E4997-5005. PMID 24297878 DOI: 10.1073/Pnas.1316517110 |
0.417 |
|
| 2013 |
Koff WC, Russell ND, Walport M, Feinberg MB, Shiver JW, Karim SA, Walker BD, McGlynn MG, Nweneka CV, Nabel GJ. Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines. Vaccine. 31: B204-8. PMID 23598483 DOI: 10.1016/J.Vaccine.2012.10.115 |
0.492 |
|
| 2012 |
Fu TM, Wang D, Freed DC, Tang A, Li F, He X, Cole S, Dubey S, Finnefrock AC, ter Meulen J, Shiver JW, Casimiro DR. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus Vaccine. 30: 7469-7474. PMID 23107592 DOI: 10.1016/J.Vaccine.2012.10.053 |
0.523 |
|
| 2012 |
Reynolds MR, Weiler AM, Piaskowski SM, Piatak M, Robertson HT, Allison DB, Bett AJ, Casimiro DR, Shiver JW, Wilson NA, Lifson JD, Koff WC, Watkins DI. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge. Vaccine. 30: 4465-75. PMID 22569124 DOI: 10.1016/J.Vaccine.2012.04.082 |
0.614 |
|
| 2012 |
Hutnick NA, Myles DJ, Hirao L, Scott VL, Ferraro B, Khan AS, Lewis MG, Miller CJ, Bett AJ, Casimiro D, Sardesai NY, Kim JJ, Shiver J, Weiner DB. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine. 30: 3202-8. PMID 22406458 DOI: 10.1016/J.Vaccine.2012.02.069 |
0.539 |
|
| 2012 |
Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, DeSilva V, Fritts L, Bett AJ, Casimiro DR, Shiver JW, Robert-Guroff M, Robertson MN, McChesney MB, Gilbert PB, et al. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. Journal of Virology. 86: 2239-50. PMID 22156519 DOI: 10.1128/JVI.06175-11 |
0.533 |
|
| 2011 |
Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, Shiver J, Caulfield M, Heinrichs JH. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine. 29: 8870-6. PMID 21964055 DOI: 10.1016/j.vaccine.2011.09.078 |
0.424 |
|
| 2011 |
Li F, Finnefrock AC, Dubey SA, Korber BT, Szinger J, Cole S, McElrath MJ, Shiver JW, Casimiro DR, Corey L, Self SG. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. Plos One. 6: e20479. PMID 21695251 DOI: 10.1371/Journal.Pone.0020479 |
0.572 |
|
| 2011 |
Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau M, Wong K, ... ... Shiver J, et al. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nature Medicine. 17: 366-71. PMID 21358627 DOI: 10.1038/Nm.2316 |
0.54 |
|
| 2011 |
Kaslow DC, Shiver JW. Clostridium difficile and methicillin-resistant Staphylococcus aureus: emerging concepts in vaccine development. Annual Review of Medicine. 62: 201-15. PMID 20707676 DOI: 10.1146/annurev-med-051109-101544 |
0.33 |
|
| 2010 |
Staprans SI, Feinberg MB, Shiver JW, Casimiro DR. Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective. Current Opinion in Hiv and Aids. 5: 377-85. PMID 20978377 DOI: 10.1097/COH.0b013e32833d2e19 |
0.486 |
|
| 2010 |
Bett AJ, Dubey SA, Mehrotra DV, Guan L, Long R, Anderson K, Collins K, Gaunt C, Fernandez R, Cole S, Meschino S, Tang A, Sun X, Gurunathan S, Tartaglia J, ... ... Shiver JW, et al. Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans. Vaccine. 28: 7881-9. PMID 20937317 DOI: 10.1016/j.vaccine.2010.09.079 |
0.6 |
|
| 2010 |
Hirao LA, Wu L, Satishchandran A, Khan AS, Draghia-Akli R, Finnefrock AC, Bett AJ, Betts MR, Casimiro DR, Sardesai NY, Kim JJ, Shiver JW, Weiner DB. Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1568-76. PMID 20551910 DOI: 10.1038/Mt.2010.112 |
0.612 |
|
| 2010 |
Bianchi E, Joyce JG, Miller MD, Finnefrock AC, Liang X, Finotto M, Ingallinella P, McKenna P, Citron M, Ottinger E, Hepler RW, Hrin R, Nahas D, Wu C, Montefiori D, ... Shiver JW, et al. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates. Proceedings of the National Academy of Sciences of the United States of America. 107: 10655-60. PMID 20483992 DOI: 10.1073/Pnas.1004261107 |
0.451 |
|
| 2010 |
Casimiro DR, Cox K, Tang A, Sykes KJ, Feng M, Wang F, Bett A, Schleif WA, Liang X, Flynn J, Tobery TW, Wilson K, Finnefrock A, Huang L, Vitelli S, ... ... Shiver JW, et al. Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge. Journal of Virology. 84: 2996-3003. PMID 20042509 DOI: 10.1128/Jvi.00969-09 |
0.616 |
|
| 2010 |
Asmuth DM, Brown EL, DiNubile MJ, Sun X, del Rio C, Harro C, Keefer MC, Kublin JG, Dubey SA, Kierstead LS, Casimiro DR, Shiver JW, Robertson MN, Quirk EK, Mehrotra DV. Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens. The Journal of Infectious Diseases. 201: 132-41. PMID 19929694 DOI: 10.1086/648591 |
0.55 |
|
| 2010 |
Mast TC, Kierstead L, Gupta SB, Nikas AA, Kallas EG, Novitsky V, Mbewe B, Pitisuttithum P, Schechter M, Vardas E, Wolfe ND, Aste-Amezaga M, Casimiro DR, Coplan P, Straus WL, ... Shiver JW, et al. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine. 28: 950-7. PMID 19925902 DOI: 10.1016/j.vaccine.2009.10.145 |
0.439 |
|
| 2010 |
Harro C, Sun X, Stek JE, Leavitt RY, Mehrotra DV, Wang F, Bett AJ, Casimiro DR, Shiver JW, Dinubile MJ, Quirk E. Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292)) Clinical and Vaccine Immunology. 17: 204. DOI: 10.1128/CVI.00473-09 |
0.476 |
|
| 2009 |
O'Brien KL, Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, Hutnick NA, Betts MR, Dubey SA, Goudsmit J, Shiver JW, Robertson MN, Casimiro DR, Barouch DH. Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nature Medicine. 15: 873-5. PMID 19620961 DOI: 10.1038/Nm.1991 |
0.568 |
|
| 2009 |
Harro C, Sun X, Stek JE, Leavitt RY, Mehrotra DV, Wang F, Bett AJ, Casimiro DR, Shiver JW, DiNubile MJ, Quirk E. Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults. Clinical and Vaccine Immunology : Cvi. 16: 1285-92. PMID 19605598 DOI: 10.1128/CVI.00144-09 |
0.411 |
|
| 2009 |
Wilson NA, Keele BF, Reed JS, Piaskowski SM, MacNair CE, Bett AJ, Liang X, Wang F, Thoryk E, Heidecker GJ, Citron MP, Huang L, Lin J, Vitelli S, Ahn CD, ... ... Shiver JW, et al. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. Journal of Virology. 83: 6508-21. PMID 19403685 DOI: 10.1128/Jvi.00272-09 |
0.604 |
|
| 2009 |
Bianchi E, Ingallinella P, Finotto M, Joyce J, Liang X, Miller MD, Kinney GG, Ciliberto G, Shiver JW, Pessi A. Synthetic peptide vaccines: the quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease. Advances in Experimental Medicine and Biology. 611: 121-3. PMID 19400121 DOI: 10.1007/978-0-387-73657-0_54 |
0.432 |
|
| 2009 |
Fu TM, Grimm KM, Citron MP, Freed DC, Fan J, Keller PM, Shiver JW, Liang X, Joyce JG. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys. Vaccine. 27: 1440-7. PMID 19146898 DOI: 10.1016/j.vaccine.2008.12.034 |
0.372 |
|
| 2009 |
Harro CD, Robertson MN, Lally MA, O'Neill LD, Edupuganti S, Goepfert PA, Mulligan MJ, Priddy FH, Dubey SA, Kierstead LS, Sun X, Casimiro DR, DiNubile MJ, Shiver JW, Leavitt RY, et al. Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults. Aids Research and Human Retroviruses. 25: 103-14. PMID 19108693 DOI: 10.1089/Aid.2008.0212 |
0.585 |
|
| 2009 |
Hirao LA, Wu L, Satishchandran A, Khan AS, Finnefrock A, Casimiro D, Shiver J, Betts MR, Sardesai NY, Weiner DB. OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques Retrovirology. 6: O32. DOI: 10.1186/1742-4690-6-S3-O32 |
0.597 |
|
| 2008 |
McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, ... Shiver JW, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet (London, England). 372: 1894-905. PMID 19012957 DOI: 10.1016/S0140-6736(08)61592-5 |
0.532 |
|
| 2008 |
Joyce JG, Krauss IJ, Song HC, Opalka DW, Grimm KM, Nahas DD, Esser MT, Hrin R, Feng M, Dudkin VY, Chastain M, Shiver JW, Danishefsky SJ. An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions. Proceedings of the National Academy of Sciences of the United States of America. 105: 15684-9. PMID 18838688 DOI: 10.1073/Pnas.0807837105 |
0.346 |
|
| 2008 |
Petravic J, Ribeiro RM, Casimiro DR, Mattapallil JJ, Roederer M, Shiver JW, Davenport MP. Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections. Journal of Virology. 82: 11589-98. PMID 18799584 DOI: 10.1128/Jvi.01596-08 |
0.493 |
|
| 2008 |
Chavez LL, Davenport MP, Shiver JW, Tussey LG, Cox KS, Bachinsky M, Wang F, Huang L, Schleif WA, Davies ME, Tang A, Casimiro DR, Perelson AS, Ribeiro RM. The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection. Virology. 381: 75-80. PMID 18793788 DOI: 10.1016/J.Virol.2008.07.042 |
0.479 |
|
| 2008 |
Cox KS, Clair JH, Prokop MT, Sykes KJ, Dubey SA, Shiver JW, Robertson MN, Casimiro DR. DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles. Journal of Virology. 82: 8161-71. PMID 18524823 DOI: 10.1128/JVI.00620-08 |
0.573 |
|
| 2008 |
Simon AJ, Casimiro DR, Finnefrock AC, Davies ME, Tang A, Chen M, Chastain M, Kath GS, Chen L, Shiver JW. Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates. Vaccine. 26: 5202-9. PMID 18472195 DOI: 10.1016/J.Vaccine.2008.03.058 |
0.348 |
|
| 2008 |
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, ... ... Shiver JW, et al. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1769-81. PMID 18433307 DOI: 10.1086/587993 |
0.498 |
|
| 2008 |
Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. Journal of Virology. 82: 2784-91. PMID 18199650 DOI: 10.1128/Jvi.01720-07 |
0.505 |
|
| 2007 |
Finnefrock AC, Liu X, Opalka DW, Shiver JW, Casimiro DR, Condra JH. HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses. Aids Research and Human Retroviruses. 23: 1283-92. PMID 17961117 DOI: 10.1089/Aid.2007.0098 |
0.484 |
|
| 2007 |
Dubey S, Clair J, Fu TM, Guan L, Long R, Mogg R, Anderson K, Collins KB, Gaunt C, Fernandez VR, Zhu L, Kierstead L, Thaler S, Gupta SB, Straus W, ... ... Shiver JW, et al. Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 20-7. PMID 17310936 DOI: 10.1097/QAI.0b013e3180377b5b |
0.492 |
|
| 2007 |
Kierstead LS, Dubey S, Meyer B, Tobery TW, Mogg R, Fernandez VR, Long R, Guan L, Gaunt C, Collins K, Sykes KJ, Mehrotra DV, Chirmule N, Shiver JW, Casimiro DR. Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC. Aids Research and Human Retroviruses. 23: 86-92. PMID 17263637 DOI: 10.1089/aid.2006.0129 |
0.52 |
|
| 2007 |
Fu TM, Dubey SA, Mehrotra DV, Freed DC, Trigona WL, Adams-Muhler L, Clair JH, Evans TG, Steigbigel R, Jacobson JM, Goepfert PA, Mulligan MJ, Kalams SA, Rinaldo C, Zhu L, ... ... Shiver JW, et al. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. Aids Research and Human Retroviruses. 23: 67-76. PMID 17263635 DOI: 10.1089/Aid.2006.0114 |
0.392 |
|
| 2006 |
Tobery TW, Dubey SA, Anderson K, Freed DC, Cox KS, Lin J, Prokop MT, Sykes KJ, Mogg R, Mehrotra DV, Fu TM, Casimiro DR, Shiver JW. A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects. Aids Research and Human Retroviruses. 22: 1081-90. PMID 17147493 DOI: 10.1089/aid.2006.22.1081 |
0.488 |
|
| 2006 |
Wu Y, Przysiecki C, Flanagan E, Bello-Irizarry SN, Ionescu R, Muratova O, Dobrescu G, Lambert L, Keister D, Rippeon Y, Long CA, Shi L, Caulfield M, Shaw A, Saul A, ... Shiver J, et al. Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proceedings of the National Academy of Sciences of the United States of America. 103: 18243-8. PMID 17110440 DOI: 10.1073/pnas.0608545103 |
0.458 |
|
| 2006 |
Gupta SB, Mast CT, Wolfe ND, Novitsky V, Dubey SA, Kallas EG, Schechter M, Mbewe B, Vardas E, Pitisuttithum P, Burke D, Freed D, Mogg R, Coplan PM, Condra JH, ... ... Shiver JW, et al. Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 135-9. PMID 16760794 DOI: 10.1097/01.qai.0000223017.01568.e7 |
0.355 |
|
| 2006 |
Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, Furlott J, Gonzalez EJ, Yant LJ, Maness NJ, May GE, Soma T, Reynolds MR, Rakasz E, Rudersdorf R, McDermott AB, ... ... Shiver JW, et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. Journal of Virology. 80: 5875-85. PMID 16731926 DOI: 10.1128/Jvi.00171-06 |
0.567 |
|
| 2006 |
Ionescu RM, Przysiecki CT, Liang X, Garsky VM, Fan J, Wang B, Troutman R, Rippeon Y, Flanagan E, Shiver J, Shi L. Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. Journal of Pharmaceutical Sciences. 95: 70-9. PMID 16315228 DOI: 10.1002/jps.20493 |
0.3 |
|
| 2006 |
Zampaglione I, Simon AJ, Capone S, Finnefrock AC, Casimiro DR, Kath GS, Tang A, Folgori A, La Monica N, Shiver J, Nicosia A, Ciliberto G, Cortese R, Fattori E. Genetic vaccination by gene electro-transfer in non-human primates Journal of Drug Delivery Science and Technology. 16: 85-89. |
0.372 |
|
| 2005 |
McDermott AB, O'Connor DH, Fuenger S, Piaskowski S, Martin S, Loffredo J, Reynolds M, Reed J, Furlott J, Jacoby T, Riek C, Dodds E, Krebs K, Davies ME, Schleif WA, ... ... Shiver JW, et al. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. Journal of Virology. 79: 15556-66. PMID 16306626 DOI: 10.1128/Jvi.79.24.15556-15566.2005 |
0.631 |
|
| 2005 |
Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, ... ... Shiver JW, et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. Journal of Virology. 79: 15547-55. PMID 16306625 DOI: 10.1128/Jvi.79.24.15547-15555.2005 |
0.544 |
|
| 2005 |
Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, ... ... Shiver JW, et al. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. Journal of Virology. 79: 12321-31. PMID 16160159 DOI: 10.1128/Jvi.79.19.12321-12331.2005 |
0.586 |
|
| 2005 |
Bianchi E, Liang X, Ingallinella P, Finotto M, Chastain MA, Fan J, Fu TM, Song HC, Horton MS, Freed DC, Manger W, Wen E, Shi L, Ionescu R, Price C, ... ... Shiver JW, et al. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. Journal of Virology. 79: 7380-8. PMID 15919893 DOI: 10.1128/JVI.79.12.7380-7388.2005 |
0.407 |
|
| 2005 |
Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B, Vardas E, Schechter M, Kallas EG, Freed DC, Fu TM, Mast CT, Puthavathana P, Kublin J, Brown Collins K, ... ... Shiver JW, et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. The Journal of Infectious Diseases. 191: 1427-34. PMID 15809900 DOI: 10.1086/428450 |
0.369 |
|
| 2004 |
Casimiro DR, Bett AJ, Fu TM, Davies ME, Tang A, Wilson KA, Chen M, Long R, McKelvey T, Chastain M, Gurunathan S, Tartaglia J, Emini EA, Shiver J. Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors. Journal of Virology. 78: 11434-8. PMID 15452269 DOI: 10.1128/JVI.78.20.11434-11438.2004 |
0.53 |
|
| 2004 |
Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, Chin S, Chen M, Zhu DM, Shiver JW, Volkin DB. Development of stable liquid formulations for adenovirus-based vaccines. Journal of Pharmaceutical Sciences. 93: 2458-75. PMID 15349956 DOI: 10.1002/jps.20157 |
0.438 |
|
| 2004 |
Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, ... ... Shiver JW, et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine. 22: 2993-3003. PMID 15297047 DOI: 10.1016/j.vaccine.2004.02.021 |
0.383 |
|
| 2004 |
Santra S, Barouch DH, Korioth-Schmitz B, Lord CI, Krivulka GR, Yu F, Beddall MH, Gorgone DA, Lifton MA, Miura A, Philippon V, Manson K, Markham PD, Parrish J, Kuroda MJ, ... ... Shiver JW, et al. Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses. Proceedings of the National Academy of Sciences of the United States of America. 101: 11088-93. PMID 15258286 DOI: 10.1073/Pnas.0401954101 |
0.578 |
|
| 2004 |
Hazuda DJ, Young SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, Dornadula G, Danovich RM, Witmer MV, Wilson KA, Tussey L, ... ... Shiver JW, et al. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science (New York, N.Y.). 305: 528-32. PMID 15247437 DOI: 10.1126/science.1098632 |
0.317 |
|
| 2004 |
Evans RK, Zhu DM, Casimiro DR, Nawrocki DK, Mach H, Troutman RD, Tang A, Wu S, Chin S, Ahn C, Isopi LA, Williams DM, Xu Z, Shiver JW, Volkin DB. Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines. Journal of Pharmaceutical Sciences. 93: 1924-39. PMID 15176079 DOI: 10.1002/jps.20112 |
0.322 |
|
| 2004 |
McGaughey GB, Barbato G, Bianchi E, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller MD, Pessi A, Shiver JW, Bogusky MJ. Progress towards the development of a HIV-1 gp41-directed vaccine. Current Hiv Research. 2: 193-204. PMID 15078183 DOI: 10.2174/1570162043484933 |
0.453 |
|
| 2004 |
Aste-Amézaga M, Bett AJ, Wang F, Casimiro DR, Antonello JM, Patel DK, Dell EC, Franlin LL, Dougherty NM, Bennett PS, Perry HC, Davies ME, Shiver JW, Keller PM, Yeager MD. Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Human Gene Therapy. 15: 293-304. PMID 15018738 DOI: 10.1089/104303404322886147 |
0.381 |
|
| 2004 |
Zhang ZQ, Schleif WA, Casimiro DR, Handt L, Chen M, Davies ME, Liang X, Fu TM, Tang A, Wilson KA, McElhaugh M, Carella A, Tan C, Connolly B, Hill S, ... ... Shiver JW, et al. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P. Virology. 320: 75-84. PMID 15003864 DOI: 10.1016/j.virol.2003.11.017 |
0.382 |
|
| 2004 |
Shiver JW, Emini EA. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annual Review of Medicine. 55: 355-72. PMID 14746526 DOI: 10.1146/annurev.med.55.091902.104344 |
0.504 |
|
| 2003 |
Geels MJ, Cornelissen M, Schuitemaker H, Anderson K, Kwa D, Maas J, Dekker JT, Baan E, Zorgdrager F, van den Burg R, van Beelen M, Lukashov VV, Fu TM, Paxton WA, van der Hoek L, ... ... Shiver JW, et al. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. Journal of Virology. 77: 12430-40. PMID 14610167 DOI: 10.1128/Jvi.77.23.12430-12440.2003 |
0.328 |
|
| 2003 |
Trigona WL, Clair JH, Persaud N, Punt K, Bachinsky M, Sadasivan-Nair U, Dubey S, Tussey L, Fu TM, Shiver J. Intracellular staining for HIV-specific IFN-gamma production: statistical analyses establish reproducibility and criteria for distinguishing positive responses. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 23: 369-77. PMID 14511463 DOI: 10.1089/107999003322226023 |
0.357 |
|
| 2003 |
Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, et al. Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies. Journal of Virology. 77: 10348-56. PMID 12970419 DOI: 10.1128/JVI.77.19.10348-10356.2003 |
0.452 |
|
| 2003 |
Subbramanian RA, Kuroda MJ, Charini WA, Barouch DH, Costantino C, Santra S, Schmitz JE, Martin KL, Lifton MA, Gorgone DA, Shiver JW, Letvin NL. Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys. Journal of Virology. 77: 10113-8. PMID 12941922 DOI: 10.1128/JVI.77.18.10113-10118.2003 |
0.572 |
|
| 2003 |
Shiver J. A non-replicating adenoviral vector as a potential HIV vaccine. Research Initiative, Treatment Action : Rita. 8: 14-6. PMID 12845771 |
0.489 |
|
| 2003 |
Casimiro DR, Tang A, Chen L, Fu TM, Evans RK, Davies ME, Freed DC, Hurni W, Aste-Amezaga JM, Guan L, Long R, Huang L, Harris V, Nawrocki DK, Mach H, ... ... Shiver JW, et al. Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. Journal of Virology. 77: 7663-8. PMID 12805466 DOI: 10.1128/Jvi.77.13.7663-7668.2003 |
0.626 |
|
| 2003 |
Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu DM, Nawrocki D, ... ... Shiver JW, et al. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene. Journal of Virology. 77: 6305-13. PMID 12743287 DOI: 10.1128/Jvi.77.11.6305-6313.2003 |
0.631 |
|
| 2003 |
McGaughey GB, Citron M, Danzeisen RC, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller M, Shiver J, Bogusky MJ. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb. Biochemistry. 42: 3214-23. PMID 12641452 DOI: 10.1021/bi026952u |
0.365 |
|
| 2003 |
Wang F, Patel DK, Antonello JM, Washabaugh MW, Kaslow DC, Shiver JW, Chirmule N. Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens. Human Gene Therapy. 14: 25-36. PMID 12573056 DOI: 10.1089/10430340360464688 |
0.329 |
|
| 2003 |
Tussey LG, Nair US, Bachinsky M, Edwards BH, Bakari J, Grimm K, Joyce J, Vessey R, Steigbigel R, Robertson MN, Shiver JW, Goepfert PA. Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization. The Journal of Infectious Diseases. 187: 364-74. PMID 12552420 DOI: 10.1086/367707 |
0.467 |
|
| 2002 |
Liang X, Fu TM, Xie H, Emini EA, Shiver JW. Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice. Vaccine. 20: 3413-21. PMID 12213412 DOI: 10.1016/S0264-410X(02)00308-0 |
0.379 |
|
| 2002 |
Caulfield MJ, Wang S, Smith JG, Tobery TW, Liu X, Davies ME, Casimiro DR, Fu TM, Simon A, Evans RK, Emini EA, Shiver J. Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines. Journal of Virology. 76: 10038-43. PMID 12208982 DOI: 10.1128/JVI.76.19.10038-10043.2002 |
0.569 |
|
| 2002 |
Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature. 415: 331-5. PMID 11797011 DOI: 10.1038/415331a |
0.592 |
|
| 2002 |
Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, Davies ME, Shiver JW, Letvin NL. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. Journal of Immunology (Baltimore, Md. : 1950). 168: 562-8. PMID 11777947 DOI: 10.4049/jimmunol.168.2.562 |
0.513 |
|
| 2002 |
Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, ... ... Shiver JW, et al. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. Journal of Virology. 76: 185-94. PMID 11739684 DOI: 10.1128/Jvi.76.1.185-194.2002 |
0.471 |
|
| 2001 |
Barouch DH, Fu TM, Montefiori DC, Lewis MG, Shiver JW, Letvin NL. Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. Immunology Letters. 79: 57-61. PMID 11595290 DOI: 10.1016/S0165-2478(01)00266-8 |
0.546 |
|
| 2001 |
Barouch DH, Craiu A, Santra S, Egan MA, Schmitz JE, Kuroda MJ, Fu TM, Nam JH, Wyatt LS, Lifton MA, Krivulka GR, Nickerson CE, Lord CI, Moss B, Lewis MG, ... ... Shiver JW, et al. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. Journal of Virology. 75: 2462-7. PMID 11160750 DOI: 10.1128/Jvi.75.5.2462-2467.2001 |
0.534 |
|
| 2001 |
Fu TM, Freed DC, Trigona WL, Guan L, Zhu L, Long R, Persaud NV, Manson K, Dubey S, Shiver JW. Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus. Journal of Virology. 75: 73-82. PMID 11119575 DOI: 10.1128/JVI.75.1.73-82.2001 |
0.313 |
|
| 2000 |
Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, ... ... Shiver JW, et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (New York, N.Y.). 290: 486-92. PMID 11039923 DOI: 10.1126/Science.290.5491.486 |
0.547 |
|
| 2000 |
Egan MA, Charini WA, Kuroda MJ, Schmitz JE, Racz P, Tenner-Racz K, Manson K, Wyand M, Lifton MA, Nickerson CE, Fu T, Shiver JW, Letvin NL. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. Journal of Virology. 74: 7485-95. PMID 10906202 DOI: 10.1128/JVI.74.16.7485-7495.2000 |
0.584 |
|
| 2000 |
Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, ... ... Shiver JW, et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proceedings of the National Academy of Sciences of the United States of America. 97: 4192-7. PMID 10759543 DOI: 10.1073/Pnas.050417697 |
0.477 |
|
| 1998 |
Barouch DH, Santra S, Steenbeke TD, Zheng XX, Perry HC, Davies ME, Freed DC, Craiu A, Strom TB, Shiver JW, Letvin NL. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. Journal of Immunology (Baltimore, Md. : 1950). 161: 1875-82. PMID 9712056 |
0.533 |
|
| 1997 |
Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, Lekutis C, Alroy M, Freed DC, Lord CI, Handt LK, Liu MA, Shiver JW. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proceedings of the National Academy of Sciences of the United States of America. 94: 9378-83. PMID 9256490 DOI: 10.1073/pnas.94.17.9378 |
0.438 |
|
| 1997 |
Liu MA, McClements W, Ulmer JB, Shiver J, Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine. 15: 909-12. PMID 9234545 DOI: 10.1016/S0264-410X(96)00280-0 |
0.499 |
|
| 1997 |
Shiver JW, Davies ME, Yasutomi Y, Perry HC, Freed DC, Letvin NL, Liu MA. Anti-HIV env immunities elicited by nucleic acid vaccines. Vaccine. 15: 884-7. PMID 9234539 DOI: 10.1016/S0264-410X(96)00251-4 |
0.458 |
|
| 1997 |
Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines Annual Review of Immunology. 15: 617-648. PMID 9143702 DOI: 10.1146/annurev.immunol.15.1.617 |
0.447 |
|
| 1997 |
Lekutis C, Shiver JW, Liu MA, Letvin NL. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. Journal of Immunology (Baltimore, Md. : 1950). 158: 4471-7. PMID 9127013 |
0.494 |
|
| 1996 |
Shiver JW, Davies ME, Perry HC, Freed DC, Liu MA. Humoral and cellular immunities elicited by HIV-1 DNA vaccination Journal of Pharmaceutical Sciences. 85: 1317-1324. PMID 8961146 DOI: 10.1021/js9600991 |
0.561 |
|
| 1996 |
Liu MA, Yasutomi Y, Davies ME, Perry HC, Freed DC, Letvin NL, Shiver JW. Vaccination of mice and nonhuman primates using HIV-gene-containing DNA Antibiotics and Chemotherapy. 48: 100-104. PMID 8726511 DOI: 10.1159/000425163 |
0.451 |
|
| 1996 |
Shiver JW, Ulmer JB, Donnelly JJ, Liu MA. Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza Advanced Drug Delivery Reviews. 21: 19-31. DOI: 10.1016/0169-409X(96)00019-1 |
0.575 |
|
| 1995 |
Shiver JW, Perry HC, Davies ME, Freed DC, Liu MA. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination Annals of the New York Academy of Sciences. 772: 198-208. PMID 8546393 DOI: 10.1111/j.1749-6632.1995.tb44745.x |
0.546 |
|
| 1995 |
Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA. Preclinical efficacy of a prototype dna vaccine: Enhanced protection against antigenic drift in influenza virus Nature Medicine. 1: 583-587. PMID 7585127 DOI: 10.1038/nm0695-583 |
0.519 |
|
| 1994 |
Montgomery DL, Donnelly JJ, Shiver JW, Liu MA, Ulmer JB. Protein expression in vivo by injection of polynucleotides Current Opinion in Biotechnology. 5: 505-510. PMID 7765464 DOI: 10.1016/0958-1669(94)90065-5 |
0.395 |
|
| 1993 |
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein Science. 259: 1745-1749. PMID 8456302 DOI: 10.1126/SCIENCE.8456302 |
0.303 |
|
| 1993 |
Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, Liu MA. Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors Dna and Cell Biology. 12: 777-783. PMID 8216848 |
0.438 |
|
| Show low-probability matches. |